Recently Viewed

News Announcement

Glenmark Pharmaceuticals: Announcement under Regulation 30 (LODR)-Press Release / Media Release

28-Jul-2026 Follow Value Research Online on Google download pdfDownload PDF Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Inc. USA launches Sugammadex Injection 200 mg/2mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan